Li M - Search Results

1

Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.

Sun JZ, Yang XX, Li XH, Xu WW, Wang Y, Zhu W, Li M. Sun JZ, et al. Among authors: li xh, li m. Dig Dis Sci. 2011 Oct;56(10):3072-7. doi: 10.1007/s10620-011-1686-y. Epub 2011 Mar 30. Dig Dis Sci. 2011. PMID: 21448695

2

Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.

Yang XX, Sun JZ, Li FX, Wu YS, Du HY, Zhu W, Li XH, Li M. Yang XX, et al. Among authors: li xh, li fx, li m. World J Gastroenterol. 2012 Jun 7;18(21):2719-26. doi: 10.3748/wjg.v18.i21.2719. World J Gastroenterol. 2012. PMID: 22690083 Free PMC article.

3

RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway.

Wang S, Huang X, Li Y, Lao H, Zhang Y, Dong H, Xu W, Li JL, Li M. Wang S, et al. Among authors: li y, li jl, li m. Hepatology. 2011 Jun;53(6):1932-42. doi: 10.1002/hep.24291. Epub 2011 May 2. Hepatology. 2011. PMID: 21391225

4

HLA class II variants in Chinese breast cancer patients.

Yang XX, Pan HZ, Li PY, Li FX, Xu WW, Wu YS, Yao GY, Li M. Yang XX, et al. Among authors: li fx, li m, li py. Asian Pac J Cancer Prev. 2011;12(11):3075-9. Asian Pac J Cancer Prev. 2011. PMID: 22393992 Free article.

5

VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells.

Zhou Z, Lu X, Zhu P, Zhu W, Mu X, Qu R, Li M. Zhou Z, et al. Among authors: li m. Biochem Biophys Res Commun. 2012 Apr 6;420(2):336-42. doi: 10.1016/j.bbrc.2012.02.160. Epub 2012 Mar 7. Biochem Biophys Res Commun. 2012. PMID: 22425983

6

Risk-association of CYP11A1 polymorphisms and breast cancer among Han Chinese women in Southern China.

Sun M, Yang X, Ye C, Xu W, Yao G, Chen J, Li M. Sun M, et al. Among authors: li m. Int J Mol Sci. 2012;13(4):4896-4905. doi: 10.3390/ijms13044896. Epub 2012 Apr 18. Int J Mol Sci. 2012. PMID: 22606018 Free PMC article.

7

Genetic Variants in MMP9 and TCF2 Contribute to Susceptibility to Lung Cancer.

Sun JZ, Yang XX, Hu NY, Li X, Li FX, Li M. Sun JZ, et al. Among authors: li x, li fx, li m. Chin J Cancer Res. 2011 Sep;23(3):183-7. doi: 10.1007/s11670-011-0183-3. Chin J Cancer Res. 2011. PMID: 23467666 Free PMC article.

8

Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis.

Yu J, Ma Q, Zhang B, Ma R, Xu X, Li M, Xu W, Li M. Yu J, et al. Among authors: li m. Sci China Life Sci. 2013 Mar;56(3):234-9. doi: 10.1007/s11427-013-4451-y. Epub 2013 Mar 23. Sci China Life Sci. 2013. PMID: 23526389 Free article.

9

Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3.

Chen JJ, Xie CM, Wang CR, Wan Y, Dong ZN, Li M, Xu WW. Chen JJ, et al. Among authors: li m. J Fluoresc. 2017 Jul;27(4):1479-1485. doi: 10.1007/s10895-017-2087-1. Epub 2017 Apr 20. J Fluoresc. 2017. PMID: 28429175

10

A risk-associated single nucleotide polymorphism of SMAD7 is common to colorectal, gastric, and lung cancers in a Han Chinese population.

Li X, Yang XX, Hu NY, Sun JZ, Li FX, Li M. Li X, et al. Among authors: li fx, li m. Mol Biol Rep. 2011 Nov;38(8):5093-7. doi: 10.1007/s11033-010-0656-3. Epub 2011 Jan 8. Mol Biol Rep. 2011. PMID: 21221812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,915 results

Search Page

Filters